Gout medication treatment patterns and adherence to standards of care from a managed care perspective.
暂无分享,去创建一个
K. Saag | H. Schumacher | Wenya Yang | C. Sarawate | A. Bakst | P. Patel | K. K. Brewer | H. Schumacher
[1] W. Bilker,et al. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). , 2005, Rheumatology.
[2] M. Becker,et al. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. , 2004, The Journal of rheumatology.
[3] R. Wortmann,et al. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. , 2004, The Journal of rheumatology.
[4] Naoyuki Kamatani,et al. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. , 2004, Arthritis and rheumatism.
[5] W. Bilker,et al. Quality of care indicators for gout management. , 2004, Arthritis and rheumatism.
[6] G. Peterson,et al. Dosage prescribing and plasma oxipurinol levels in patients receiving allopurinol therapy , 2004, European Journal of Clinical Pharmacology.
[7] S. Kong,et al. A literature review of the epidemiology and treatment of acute gout. , 2003, Clinical therapeutics.
[8] M D Harris,et al. Gout and hyperuricemia. , 1999, American family physician.
[9] J. Rizzo,et al. Variations in compliance among hypertensive patients by drug class: implications for health care costs. , 1997, Clinical therapeutics.
[10] D. Hosmer,et al. A comparison of goodness-of-fit tests for the logistic regression model. , 1997, Statistics in medicine.
[11] P. F. Adams,et al. Current estimates from the National Health Interview Survey, 1994. , 1995, Vital and health statistics. Series 10, Data from the National Health Survey.
[12] P. Pillans,et al. A survey of allopurinol dosage prescribing. , 1995, The New Zealand medical journal.
[13] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[14] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[15] F. Harrell,et al. Regression modelling strategies for improved prognostic prediction. , 1984, Statistics in medicine.